Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a profound impact on the world’s health and economy. Although the end of the pandemic may come in 2023, it is generally believed that the virus will not be completely eradic...
Main Authors: | Corbin England, Jonathan TrejoMartinez, Paula PerezSanchez, Uddhab Karki, Jianfeng Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/13/3/617 |
Similar Items
-
Editorial: Plant products for antiviral therapeutics
by: Anirban Mandal, et al.
Published: (2022-10-01) -
Cyclodextrins in Antiviral Therapeutics and Vaccines
by: Susana Santos Braga, et al.
Published: (2021-03-01) -
Antivirals for Broader Coverage against Human Coronaviruses
by: Mia Outteridge, et al.
Published: (2024-01-01) -
Evaluation of Microalgae Antiviral Activity and Their Bioactive Compounds
by: Dora Allegra Carbone, et al.
Published: (2021-06-01) -
Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics
by: Kok Gan Chan, et al.
Published: (2021-11-01)